Why is ARGX Down Today?
About argenx SE American Depositary Shares
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also receive...
Overall Confidence: 50%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
Biological Products, (No Diagnostic Substances) sector: -0.6%
Market Comparison
🔔 Get ARGX Alerts
We'll notify you when ARGX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
ARGX has moved more than 3.0% down on 13 occasions in the past year.
Frequently Asked Questions
Why is ARGX stock down today?
ARGX is down 2.1% today on 0.9x average volume. The move appears to be driven by general market sentiment and momentum traders.
Is ARGX stock a buy or sell right now?
Based on current analysis, ARGX shows 50% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the ARGX stock price target?
ARGX is currently trading at $915.98. Based on today's momentum, the expected short-term range is $888.50 - $934.29. See long-term price prediction →
Will ARGX stock continue falling?
Our analysis shows a 45% probability that ARGX's move continues in the next 1-3 days. Key level to watch: $870.18 (support).
Is ARGX stock oversold or overbought?
ARGX's RSI (Relative Strength Index) is currently at 35.7. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for ARGX stock?
ARGX's 10-day momentum indicator is at -71.11. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is ARGX outperforming or underperforming the market?
ARGX (-2.14%) is currently significantly underperforming the market (-2.9% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for ARGX?
ARGX's MACD (-9.69) is currently below the signal line (-1.43), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 18.2) is weak.
Is ARGX in an uptrend or downtrend?
Based on moving average analysis, ARGX is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $976.43, 50-day SMA: $956.72.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis